Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Financials

$9.56

$0.05 (-0.52%)
Last update: 04:00 PM EST
Day's range
$9.29
Day's range
$9.82

BHVN Income statement / Annual

Last year (2024), Biohaven Ltd.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Biohaven Ltd.'s net income was -$846.42 M. See Biohaven Ltd.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0 0 0
Research and Development Expenses $795.87 M $373.28 M $437.07 M $181.49 M $98.46 M $344.67 M
General & Administrative Expenses $89.24 M $62.77 M $130.86 M $37.41 M $16.05 M $134.45 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $89.24 M $62.77 M $130.86 M $37.41 M $16.05 M $134.45 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $885.11 M $436.05 M $567.93 M $218.90 M $114.51 M $479.12 M
Cost And Expenses $885.11 M $436.05 M $567.93 M $218.90 M $114.51 M $479.12 M
Interest Income $21.33 M $17.73 M $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 -$12.71 M
Depreciation & Amortization $7.86 M $6.91 M $1.39 M $1.39 M $72.00 K $171.86 K
EBITDA -$877.26 M -$429.14 M -$566.55 M -$217.51 M -$114.43 M -$479.12 M
EBITDA Ratio 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0
Total Other Income/Expenses Net $39.42 M $26.50 M -$1.91 M $6.47 M -$4.16 M -$49.26 M
Income Before Tax -$845.69 M -$409.55 M -$569.84 M -$212.43 M -$118.67 M -$528.39 M
Income Before Tax Ratio 0 0 0 0 0 0
Income Tax Expense $735.00 K -$1.38 M $438.00 K $1.37 M $0.00 $419.00 K
Net Income -$846.42 M -$408.17 M -$570.28 M -$213.80 M -$118.67 M -$528.81 M
Net Income Ratio 0 0 0 0 0 0
EPS -9.28 -5.73 -12.75 -5.97 -3.31 -10.91
EPS Diluted -9.28 -5.73 -12.75 -5.97 -3.31 -10.91
Weighted Average Shares Out $91.23 M $71.20 M $44.74 M $35.82 M $35.82 M $48.49 M
Weighted Average Shares Out Diluted $91.23 M $71.20 M $44.74 M $35.82 M $35.82 M $48.49 M
Link